In the past several years, the united kingdom has witnessed a revolution in clinical fat‑loss remedies — with the introduction of semaglutide (Wegovy®) towards the growing attractiveness of tirzepatide (Mounjaro®). Now, An additional name is drawing attention in equally medical and public health